Exploring the use of heparin as a first capture step in the purification of monoclonal antibodies from cell culture supernatants

Abstract

Listen

Translate article

In this work, an innovative and cost effective alternative to Protein A based on a commercially available HiTrap™ Heparin resin was evaluated as a first capture step for the purification of a monoclonal antibody from different CHO cell culture supernatants. Preliminary studies using pure human serum antibodies and fetal bovine serum showed that heparin can be used as a cation exchanger for the capture of antibodies. Different adsorption and elution buffers were screened and the most promising results were obtained using 20mM phosphate buffer at pH 8.0 as binding buffer and 1M NaCl in 20mM phosphate buffer at pH 8.0 as elution buffer. The performance of the capture step was evaluated in terms of yield, purity, and purification factor of the elution pool obtained. The studies revealed that heparin is capable of an impressive performance, with recoveries higher than 96% from a diafiltered serum-free CHO cell supernatant for all tested conditions (pH 7.0–8.0), and surpassing 99% at pH 8.0. This is especially important considering that the separation did not rely on a highly selective bioaffinity step. The purification factor was found to increase with the pH value, with the highest value (representing a 3.1-fold increase) also obtained at pH 8.0.